(1r)-1-(3-Bromo-4-fluorophenyl)ethan-1-ol, 97%, 250mg

(E)-1-(4-(Decyloxy)-3-methylphenyl)-2-(4-(decyloxy)phenyl)diazene, 95% HPLC, 1g

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)

Chromium carbonyl, 98.0%, 1g

3-bromo-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile, 95.0%, 1g

(R)-1,5-Dimethylpiperazin-2-one hydrochloride, 97.0%, 1g

Reagent reservoirs Contents 100 ml, Non sterile, 10 x 10, 100 pieces, 100 pieces

3-Bromophenyl-(2-methylbenzyl)ether, 97.0%, 5g

6-((4R,5S)-5-Methyl-2-oxoimidazolidin-4-yl)hexanoic acid, 97%, 5g

6-Bromo-8-chloro-4(3H)-quinazolinone, 1g

4-Chloro-2-(trifluoromethoxy)benzoyl chloride, 1g

4-Bromo-N,N,2-trimethylbenzenesulfonamide, 97%, 250mg

5-Chloro-2,4-difluorobenzonitrile, 95.0%, 1g